1.Prof.Hu Kai gave an oral presentation on the theme of"Aoto Hematopoietic Stem Cell transplantation Combined with Another Target Humanized CAR-T Cells for Refractory/Relapsed B-cell Non-Hodgkin Lymphoma after Failure of Murinized CD19 CAR-T Therapy".

2.Prof.Liu Ying gave an oral presentation on the theme of"Efficacy and Safety of Sequential Different B Cell Antigen-Targeted CAR-T-Cell Therapy for Pediatric Refractory/Relapsed Burkitt Lymphoma with Secondary Central Nervous System Involvement".

3.Prof.Yang Fan gave an oral presentation on the theme of"Allogeneic Hematopoietic Stem Cell Transplantation with Conditioning Including Donor Humanized CAR-T Cells for Refractory/Relapsed B-Cell Non-Hodgkin Lymphoma and Multiple Myeloma".

4.Dr.Wang Shan made a poster display with the theme of"ALK inhibitor plus Vinblasitine for refractory/relapsed pediatric ALK+anaplastic large cell lymphoma:A prospective,one-arm,open-label real-world study".

5.Prof.Li Zhihui made a poster display with the theme of"Long-Term Follow-up of Allogeneic Hematopoietic Stem Cell Transplantation after Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia"and"Allogeneic Hematopoietic Stem Cell Transplantation for Refractory/Relapsed T Cell Acute Lymphoblastic Leukemia/Lymphoma after Donor-Derived CD7-Chimeric Antigen Receptor T-Cell Therapy".

6.Dr.Song Yanzhi made a poster display with the theme of"Allogeneic-Hematopoietic Stem Cell Transplantation Is Effective and Safe for Relapsed/Refractory B-ALL Patients Who Cannot Get Remission or MRD Negative after CAR-T Treatment".

7.Dr.Shi Hui was selected as the abstract of the paper on the topic"Secondary Humanized CAR-T Cells Salvage Therapy Improves Survival of R/R DLBCL Patients Failed to Murine CD19-CAR-T Cells Therapy".